Trehalose- and glucose-derived glycoamphiphiles: small-molecule and nanoparticle Toll-like receptor 4 (TLR4) modulators.

An increasing number of pathologies have been linked to Toll-like receptor 4 (TLR4) activation and signaling, therefore new hit and lead compounds targeting this receptor activation process are urgently needed. We report on the synthesis and biological properties of glycolipids based on glucose and trehalose scaffolds which potently inhibit TLR4 activation and signaling in vitro and in vivo. Structure-activity relationship studies on these compounds indicate that the presence of fatty ester chains in the molecule is a primary prerequisite for biological activity and point to facial amphiphilicity as a preferred architecture for TLR4 antagonism. The cationic glycolipids here presented can be considered as new lead compounds for the development of drugs targeting TLR4 activation and signaling in infectious, inflammatory, and autoimmune diseases. Interestingly, the biological activity of the best drug candidate was retained after adsorption at the surface of colloidal gold nanoparticles, broadening the options for clinical development.

[1]  F. Santoyo-González,et al.  Dynamic self-assembly of polycationic clusters based on cyclodextrins for pH-sensitive DNA nanocondensation and delivery by component design. , 2014, Chemistry.

[2]  F. Peri,et al.  Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update. , 2014, Journal of medicinal chemistry.

[3]  F. Granucci,et al.  Modulation of CD14 and TLR4⋅MD‐2 Activities by a Synthetic Lipid A Mimetic , 2014, Chembiochem : a European journal of chemical biology.

[4]  C. Oostenbrink,et al.  Conformationally Constrained Lipid A Mimetics for Exploration of Structural Basis of TLR4/MD-2 Activation by Lipopolysaccharide , 2013, ACS chemical biology.

[5]  Alison J. Scott,et al.  The TLR4 antagonist Eritoran protects mice from lethal influenza infection , 2013, Nature.

[6]  Michael Maes,et al.  Role of the Toll Like Receptor (TLR) Radical Cycle in Chronic Inflammation: Possible Treatments Targeting the TLR4 Pathway , 2013, Molecular Neurobiology.

[7]  J. Ruysschaert,et al.  Cationic lipids activate intracellular signaling pathways. , 2012, Advanced drug delivery reviews.

[8]  Koichi Fukase,et al.  Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2 , 2012, Proceedings of the National Academy of Sciences.

[9]  F. Santoyo-González,et al.  β-Cyclodextrin-based polycationic amphiphilic "click" clusters: effect of structural modifications in their DNA complexing and delivery properties. , 2011, The Journal of organic chemistry.

[10]  H. Frey,et al.  Rapid Access to Polyfunctional Lipids with Complex Architecture via Oxyanionic Ring-Opening Polymerization , 2011 .

[11]  F. Granucci,et al.  Uniform lipopolysaccharide (LPS)-loaded magnetic nanoparticles for the investigation of LPS-TLR4 signaling. , 2011, Angewandte Chemie.

[12]  F. Santoyo-González,et al.  Non-Magnetic and Magnetic Supported Copper(I) Chelating Adsorbents as Efficient Heterogeneous Catalysts and Copper Scavengers for Click Chemistry , 2010 .

[13]  F. Peri,et al.  The cationic amphiphile 3,4-bis(tetradecyloxy)benzylamine inhibits LPS signaling by competing with endotoxin for CD14 binding. , 2010, Biochemical pharmacology.

[14]  D. Gray,et al.  Quantum dots decorated with pathogen associated molecular patterns as fluorescent synthetic pathogen models. , 2010, Molecular bioSystems.

[15]  J. M. Benito,et al.  Preorganized, macromolecular, gene-delivery systems. , 2010, Chemistry.

[16]  Liping Yu,et al.  Evidence of a specific interaction between new synthetic antisepsis agents and CD14. , 2009, Biochemistry.

[17]  Nicolas Guilloteau,et al.  Polycationic amphiphilic cyclodextrins for gene delivery: synthesis and effect of structural modifications on plasmid DNA complex stability, cytotoxicity, and gene expression. , 2009, Chemistry.

[18]  F. Santoyo-González,et al.  Preorganized macromolecular gene delivery systems: amphiphilic beta-cyclodextrin "click clusters". , 2009, Organic & biomolecular chemistry.

[19]  Hayyoung Lee,et al.  The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex , 2009, Nature.

[20]  B. Costa,et al.  Glycolipids and benzylammonium lipids as novel antisepsis agents: synthesis and biological characterization. , 2009, Journal of medicinal chemistry.

[21]  J. Gatot,et al.  DiC14‐amidine cationic liposomes stimulate myeloid dendritic cells through Toll‐like receptor 4 , 2008, European journal of immunology.

[22]  E. Álvarez,et al.  Synthesis, structure, and inclusion capabilities of trehalose-based cyclodextrin analogues (cyclotrehalans). , 2008, The Journal of organic chemistry.

[23]  G. Martin,et al.  Expanding the global epidemiology of sepsis. , 2007, Critical care medicine.

[24]  R. Jerala.  Structural biology of the LPS recognition. , 2007, International journal of medical microbiology : IJMM.

[25]  Hayyoung Lee,et al.  Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran , 2007, Cell.

[26]  Leaf Huang,et al.  Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines. , 2007, Molecular immunology.

[27]  Leaf Huang,et al.  Immunostimulation of dendritic cells by cationic liposomes , 2006, Molecular membrane biology.

[28]  S. Paik,et al.  Crystal Structure of CD14 and Its Implications for Lipopolysaccharide Signaling*♦ , 2005, Journal of Biological Chemistry.

[29]  J. Madrenas,et al.  Polycationic lipids inhibit the pro-inflammatory response to LPS. , 2005, Immunology letters.

[30]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[31]  D. Persing,et al.  Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents , 2004, Expert opinion on biological therapy.

[32]  Joachim O. Rädler,et al.  Hydrophobic Nanocrystals Coated with an Amphiphilic Polymer Shell: A General Route to Water Soluble Nanocrystals , 2004 .

[33]  N. Coussens,et al.  Isolation of an endotoxin–MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Yoshinori Nagai,et al.  MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4 , 1999, The Journal of experimental medicine.

[35]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[36]  G. Prestwich,et al.  Asymmetric total synthesis of D-myo-inositol 1,2,4,5-tetrakisphosphate and its P-2-(O-aminopropyl) derivative , 1996 .

[37]  J. F. Mota,et al.  Isothiocyanates and cyclic thiocarbamates of α, α′-trehalose, sucrose, and cyclomaltooligosaccharides , 1995 .

[38]  K. Ariga,et al.  Bis(alkylguanidinium) Receptors for Phosphodiesters: Effect of Counterions, Solvent Mixtures, and Cavity Flexibility on Complexation. , 1994 .

[39]  K. Ariga,et al.  Bis(alkylguanidinium) receptors for phosphodiesters: effect of counterions, solvent mixtures, and cavity flexibility on complexation , 1993 .

[40]  D. Golenbock,et al.  Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. , 1991, The Journal of biological chemistry.

[41]  I. Tvaroška,et al.  Anomeric and Exo-Anomeric Effects in Carbohydrate Chemistry , 1991 .

[42]  R. Ulevitch,et al.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.

[43]  R. Ulevitch,et al.  Structure and function of lipopolysaccharide binding protein. , 1990, Science.

[44]  A. Liav,et al.  An improved synthesis of (2,3,4-tri-O-acetyl-α-d-glucopyranosyl)uronic acid (2,3,4-tri-O-acetyl-α-d-glucopyranosid)uronic acid , 1980 .

[45]  B. Samuelsson,et al.  Novel reagent system for converting a hydroxy-group into an iodo-group in carbohydrates with inversion of configuration , 1980 .

[46]  F. Peri,et al.  Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists. , 2012, Biotechnology advances.

[47]  F. Granucci,et al.  Synthesis and biological evaluation of novel lipid A antagonists. , 2006, Bioorganic & medicinal chemistry.

[48]  T. Klar,et al.  Time Resolved Fluorescence Measurements of Fluorophores Close to Metal Nanoparticles , 2005 .

[49]  V. Křen,et al.  Synthesis of a Precursor of a Lipid A Mimic , 2003 .

[50]  B. Beutler,et al.  TLR4 as the mammalian endotoxin sensor. , 2002, Current topics in microbiology and immunology.

[51]  Y. Gololobov,et al.  Sixty years of staudinger reaction , 1981 .